Advertisement
Screener

PRO-DEX, INC. (PDEX) Current Ratio

PRO-DEX, INC. (PDEX) Current Ratio

  • Current ratio · latest quarter: Value 4.10×; Formula and calculation Current assets / current liabilities..

Current ratio

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Current ratio · latest quarter4.10×Current assets / current liabilities.

$53.25M ÷ $12.98M ≈ 4.10×

Calculation inputs

InputAmount with unitRaw financial data
Current assets53.25M USDAssets, Current
Current obligations12.98M USDLiabilities, Current
Cash and equivalents8.19M USDCash and Cash Equivalents, at Carrying Value
Short-term securities1.15M USDMarketable Securities, Current
Customer receivables21.20M USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory21.46M USDInventory, Net
Payables4.26M USDAccounts Payable, Current
Borrowing debt due within one year(m)

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCurrent assets (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory (USD)Payables (USD)Borrowing debt due within one year (USD)Current ratio
2026-06-30$53.25M$12.98M$8.19M$1.15M$21.20M$21.46M$4.26M(m)4.10×
2026-03-31$53.71M$14.64M$6.63M$986.00K$19.47M$22.36M$5.25M(m)3.67×
2025-12-31$49.19M$12.20M$5.27M$864.00K$17.88M$21.71M$4.11M(m)4.03×
2025-09-30$50.72M$13.60M$33.00K$10.04M$18.23M$21.56M$3.96M(m)3.73×
2025-06-30$47.30M$14.63M$419.00K$6.74M$16.43M$22.21M$4.61M(m)3.23×
2025-03-31$49.94M$18.32M$33.00K$5.42M$15.86M$23.43M$5.96M(m)2.73×
2024-12-31$44.30M$17.14M$66.00K$4.67M$18.47M$19.61M$5.69M(m)2.58×
2024-09-30$38.50M$11.29M$3.08M$4.74M$13.46M$16.60M$4.44M(m)3.41×
2024-06-30$36.61M$12.89M$2.63M$4.22M$13.89M$15.27M$4.51M(m)2.84×
2024-03-31$35.96M$10.42M$3.22M$1.00M$12.52M$14.24M$3.44M(m)3.45×
2023-12-31$36.60M$9.99M$1.29M$763.00K$13.17M$15.03M$2.91M(m)3.66×
2023-09-30$31.42M$8.28M$1.90M$1.01M$11.03M$16.26M$2.74M(m)3.79×
2023-06-30$30.98M$9.68M$2.94M$1.13M$9.95M$16.17M$2.26M(m)3.20×
2023-03-31$31.14M$10.14M$2.09M(m)$10.56M$15.14M$3.07M(m)3.07×
2022-12-31$31.39M$11.66M$382.00K(m)$12.20M$15.13M$3.36M(m)2.69×
2022-09-30$31.84M$11.67M$2.80M(m)$11.04M$15.66M$3.55M(m)2.73×
2022-06-30$31.17M$11.35M$849.00K$755.00K$15.38M$12.68M$3.76M(m)2.74×
2022-03-31$28.10M$7.72M$4.76M$1.13M$8.68M$11.87M$3.53M(m)3.64×
2021-12-31$26.09M$5.97M$5.25M$1.24M$8.85M$9.29M$2.31M(m)4.37×
2021-09-30$26.02M$6.21M$5.18M$1.51M$10.09M$8.91M$2.48M(m)4.19×
2021-06-30$25.01M$6.27M$3.72M(m)$10.93M$8.44M$2.29M(m)3.99×
2021-03-31$26.57M$6.48M$3.87M$1.12M$11.92M$8.37M$2.52M(m)4.10×
2020-12-31$22.71M$4.93M$5.52M$2.88M$4.62M$9.15M$2.47M(m)4.60×
2020-09-30$22.54M$4.45M$5.20M$2.40M$6.14M$8.31M$1.83M(m)5.06×
2020-06-30$22.67M$5.23M$6.42M(m)$5.16M$8.24M$1.97M(m)4.34×
2020-03-31$20.58M$4.44M$4.38M$2.77M$4.17M$8.64M$1.91M(m)4.64×
2019-12-31$20.89M$3.95M$6.17M$3.54M$2.68M$7.81M$1.67M(m)5.29×
2019-09-30$20.36M$3.55M$6.50M$3.13M$3.16M$6.84M$1.38M(m)5.74×
2019-06-30$20.84M$4.27M$7.74M(m)$4.10M$6.24M$2.00M(m)4.88×
2019-03-31$22.06M$3.75M$9.66M$2.81M$3.74M$4.80M$1.54M(m)5.88×
2018-12-31$20.77M$2.67M$8.87M(m)$3.81M$4.54M$970.00K(m)7.77×
2018-09-30$21.59M$2.90M$8.31M(m)$3.62M$4.57M$1.20M(m)7.43×
2018-06-30$16.23M$2.42M$5.19M(m)$2.96M$4.39M$1.08M(m)6.72×
2018-03-31$14.88M$1.96M$5.10M(m)$3.43M$3.38M$873.00K(m)7.61×
2017-12-31$13.94M$1.97M$5.26M(m)$3.15M$3.20M$923.00K(m)7.07×
2017-09-30$13.79M$1.79M$5.86M(m)$2.25M$3.51M$943.00K(m)7.69×
2017-06-30$12.28M$2.58M$4.21M(m)$3.54M$3.08M$1.16M(m)4.76×
2017-03-31$11.15M$2.35M$3.70M(m)$3.88M$2.98M$946.00K(m)4.74×
2016-12-31$10.22M$2.72M$2.18M(m)$1.03M$3.27M$761.00K(m)3.76×
2016-09-30$9.82M$2.65M$2.17M(m)$1.54M$3.37M$1.18M(m)3.70×
2016-06-30$9.29M$2.16M$2.29M(m)$1.47M$3.36M$841.00K(m)4.31×
2016-03-31$9.69M$2.17M$1.45M(m)$2.17M$4.12M$1.13M(m)4.47×
2015-12-31$10.02M$3.13M$1.05M(m)$1.83M$4.48M$1.29M(m)3.20×
2015-09-30$8.27M$3.61M$493.00K(m)$759.00K$4.25M$1.21M(m)2.29×
2015-06-30$8.41M$3.69M$697.00K(m)$2.33M$4.31M$1.87M(m)2.28×
2015-03-31$9.99M$3.78M$1.48M(m)$2.10M$3.44M$1.53M(m)2.64×
2014-12-31$8.97M$2.69M$1.97M(m)$1.11M$2.88M$830.00K(m)3.33×
2014-09-30$8.75M$2.13M$3.61M(m)$1.09M$2.59M$617.00K(m)4.10×
2014-06-30$8.89M$2.13M$3.19M(m)$1.78M$2.60M$744.00K(m)4.18×
2014-03-31$7.54M$2.21M$1.93M(m)$1.10M$3.18M$603.00K(m)3.42×
2013-12-31$7.58M$2.02M$1.55M(m)$1.58M$3.55M$626.00K(m)3.76×
2013-09-30$7.78M$1.89M$1.83M(m)$1.36M$3.97M$482.00K(m)4.11×
2013-06-30$7.35M$2.31M$1.68M(m)$1.34M$3.83M$844.00K(m)3.18×
2013-03-31$8.28M$2.25M$2.04M(m)$1.58M$3.75M$981.00K(m)3.68×
2012-12-31$8.24M$1.63M$2.55M(m)$1.18M$3.52M$576.00K(m)5.06×
2012-09-30$9.36M$2.62M$3.13M(m)$1.84M$3.48M$1.11M(m)3.57×
2012-06-30$9.50M$2.88M$4.11M(m)$1.58M$2.79M$633.00K(m)3.30×
2012-03-31$11.02M$3.38M$4.88M(m)$2.23M$3.06M$1.03M(m)3.26×
2011-12-31$11.70M$3.75M$4.27M(m)$2.25M$4.73M$1.62M(m)3.11×
2011-09-30$11.73M$3.40M$4.91M(m)$2.33M$4.04M$1.16M(m)3.45×
2011-06-30$11.84M$4.02M$4.69M(m)$3.13M$3.70M$1.21M(m)2.94×

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Neuronetics, Inc. (STIM)United States$0.216B-3.25
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Profound Medical Corp. (PROF)$0.206B-7.37
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32